185 related articles for article (PubMed ID: 15863250)
1. Beneficial cardio-renovascular effects of a low-molecular-weight heparin-derivative on adriamycin-induced glycosaminoglycanuria and tissue lipid abnormalities.
Deepa PR; Varalakshmi P
Toxicology; 2005 Jul; 211(1-2):77-85. PubMed ID: 15863250
[TBL] [Abstract][Full Text] [Related]
2. Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity.
Deepa PR; Varalakshmi P
Toxicology; 2006 Jan; 217(2-3):176-83. PubMed ID: 16242830
[TBL] [Abstract][Full Text] [Related]
3. Biochemical evaluation of the inflammatory changes in cardiac, hepatic and renal tissues of adriamycin-administered rats and the modulatory role of exogenous heparin-derivative treatment.
Deepa PR; Varalakshmi P
Chem Biol Interact; 2005 Oct; 156(2-3):93-100. PubMed ID: 16154121
[TBL] [Abstract][Full Text] [Related]
4. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats.
Deepa PR; Varalakshmi P
Clin Chim Acta; 2005 May; 355(1-2):119-30. PubMed ID: 15820486
[TBL] [Abstract][Full Text] [Related]
5. Favourable modulation of the inflammatory changes in hypercholesterolemic atherogenesis by a low-molecular-weight heparin derivative.
Deepa PR; Varalakshmi P
Int J Cardiol; 2006 Jan; 106(3):338-47. PubMed ID: 16337042
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of DL-alpha-lipoic acid on cyclophosphamide induced hyperlipidemic cardiomyopathy.
Mythili Y; Sudharsan PT; Sudhahar V; Varalakshmi P
Eur J Pharmacol; 2006 Aug; 543(1-3):92-6. PubMed ID: 16814280
[TBL] [Abstract][Full Text] [Related]
7. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.
El-Shitany NA; El-Haggar S; El-desoky K
Food Chem Toxicol; 2008 Jul; 46(7):2422-8. PubMed ID: 18487002
[TBL] [Abstract][Full Text] [Related]
8. Biochemical study on the protective potential of Nardostachys jatamansi extract on lipid profile and lipid metabolizing enzymes in doxorubicin intoxicated rats.
Subashini R; Ragavendran B; Gnanapragasam A; Yogeeta SK; Devaki T
Pharmazie; 2007 May; 62(5):382-7. PubMed ID: 17557749
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity.
Yilmaz S; Atessahin A; Sahna E; Karahan I; Ozer S
Toxicology; 2006 Feb; 218(2-3):164-71. PubMed ID: 16325981
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
Stanely Mainzen Prince P; Kannan NK
J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
[TBL] [Abstract][Full Text] [Related]
11. The cytoprotective role of a low-molecular-weight heparin fragment studied in an experimental model of glomerulotoxicity.
Deepa PR; Varalakshmi P
Eur J Pharmacol; 2003 Oct; 478(2-3):199-205. PubMed ID: 14575805
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity.
Deepa PR; Varalakshmi P
Chem Biol Interact; 2003 Oct; 146(2):201-10. PubMed ID: 14597133
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of abnormalities in the lipid metabolism during experimental myocardial infarction induced by isoproterenol in rats: beneficial effect of ferulic acid and ascorbic acid.
Yogeeta SK; Hanumantra RB; Gnanapragasam A; Senthilkumar S; Subhashini R; Devaki T
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):467-72. PubMed ID: 16635105
[TBL] [Abstract][Full Text] [Related]
14. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
Kalaiarasi P; Kaviarasan K; Pugalendi KV
Eur J Pharmacol; 2009 Jun; 612(1-3):93-7. PubMed ID: 19361497
[TBL] [Abstract][Full Text] [Related]
15. Lipid lowering: an important factor in preventing adriamycin-induced heart failure.
Iliskovic N; Singal PK
Am J Pathol; 1997 Feb; 150(2):727-34. PubMed ID: 9033285
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats.
Giri SN; Al-Bayati MA; Du X; Schelegle E; Mohr FC; Margolin SB
Cancer Chemother Pharmacol; 2004 Feb; 53(2):141-50. PubMed ID: 14564477
[TBL] [Abstract][Full Text] [Related]
17. Green tea extract impedes dyslipidaemia and development of cardiac dysfunction in streptozotocin-diabetic rats.
Anandh Babu PV; Sabitha KE; Shyamaladevi CS
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1184-9. PubMed ID: 17184499
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparin does not necessarily reduce lipids and lipoproteins in hemodialysis patients.
Kronenberg F; König P; Lhotta K; Steinmetz A; Dieplinger H
Clin Nephrol; 1995 Jun; 43(6):399-404. PubMed ID: 7554525
[TBL] [Abstract][Full Text] [Related]
19. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
[TBL] [Abstract][Full Text] [Related]
20. [The protective effect of low molecular weight heparin on early nephropathy in diabetic rats].
Guo H; Gan L; Yu Z
Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(21):1327-9. PubMed ID: 16200729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
